Evidence map›Paper›PMID 18444252›Full record

ArticleAmerican journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics2008

Neurotransmission and bipolar disorder: a systematic family-based association study.

Jiajun Shi, Judith A Badner, Eiji Hattori, James B Potash, Virginia L Willour, Francis J McMahon, Elliot S Gershon, Chunyu Liu

Open access · greenAbstract read
In one paragraph

Article in American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. VMAT2 gene (Pharmacogenomics · 2019
    Article
  9. Article
  10. Development of an AmpliSeqFrontiers in pharmacology · 2018
    Article
  11. Article
  12. Article
  13. Association of GRM4 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma in Guangxi Chinese population.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Jiajun ShiDepartment of Psychiatry, University of Chicago, Chicago, Illinois 60637, USA. kjacobso@bsd.uchicago.edu
Judith A Badner
Eiji Hattori
James B Potash
Virginia L Willour
Francis J McMahon
Elliot S Gershon
Chunyu Liu
University of Chicago · USJohns Hopkins University · USNational Institute of Mental Health · USRIKEN Center for Brain Science · JPUniversity of Illinois Chicago · US

Funding

Identification of Genes Involved in Major Mood DisordersZIAMH002843 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI MCMAHON, FRANCIS J · 2009 to 2025
$24.5M
Fine Genomic Mapping of 13q32 in Bipolar DisorderR01MH065560 · NIMH · UNIVERSITY OF CHICAGO · PI GERSHON, ELLIOT S · 2002 to 2006
$3.0M
GENETIC LINKAGE STUDIES IN BIPOLAR DISORDERSR01MH061613 · NIMH · UNIVERSITY OF CHICAGO · PI GERSHON, ELLIOT S · 2000 to 2009
$2.8M
The Genetic and Genomic Study of MicroRNA in Bipolar and SchizophreniaR01MH080425 · NIMH · UNIVERSITY OF CHICAGO · PI LIU, CHUNYU · 2007 to 2010
$2.6M
Alternate Phenotypes of Substance AbuseR01DA018662 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TSUANG, MING T. · 2004 to 2006
$761k
NIAAA NIH HHS AA00231NIAAA NIH HHS U10AA0503NIDA NIH HHS 5R01DA018662NIMH NIH HHS R01 MH061613NIMH NIH HHS R01 MH065560NIMH NIH HHS R01 MH080425Wellcome Trust
6 · The paper itself

Abstract

Neurotransmission pathways/systems have been proposed to be involved in the pathophysiology and treatment of bipolar disorder for over 40 years. In order to test the hypothesis that common variants of genes in one or more of five neurotransmission systems confer risk for bipolar disorder, we analyzed 1,005 tag single nucleotide polymorphisms in 90 genes from dopaminergic, serotonergic, noradrenergic, GABAergic, and glutamatergic neurotransmitter systems in 101 trios and 203 quads from Caucasian bipolar families. Our sample has 80% power to detect ORs >or= 1.82 and >or=1.57 for minor allele frequencies of 0.1 and 0.5, respectively. Nominally significant allelic and haplotypic associations were found for genes from each neurotransmission system, with several reaching gene-wide significance (allelic: GRIA1, GRIN2D, and QDPR; haplotypic: GRIN2C, QDPR, and SLC6A3). However, none of these associations survived correction for multiple testing in an individual system, or in all systems considered together. Significant single nucleotide polymorphism associations were not found with sub-phenotypes (alcoholism, psychosis, substance abuse, and suicide attempts) or significant gene-gene interactions. These results suggest that, within the detectable odds ratios of this study, common variants of the selected genes in the five neurotransmission systems do not play major roles in influencing the risk for bipolar disorder or comorbid sub-phenotypes.

Indexed as

Family HealthGenetic Predisposition to DiseaseBipolar DisorderHumansNeurotransmitter AgentsOdds RatioPhenotypePolymorphism, Single NucleotideWhite PeopleNeurotransmitter Agents

Identifiers

PMID18444252
PMCPMC2574701
OpenAlexW2131845440

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.